Amendment to the Drug Administration Law, intends to impose heavy penalties on t

Copyfrom： Release time：2018-10-24 The editor：

Amendment to the Drug Administration Law, intends to impose heavy penalties on the production and sale of counterfeit drugs

Heavy penalty for the production and sale of counterfeit drugs
 
According to Xinhua News, the draft amendment to the Drug Administration Law was submitted to the Standing Committee of the National People's Congress for deliberation on 22nd, and the draft will comprehensively increase penalties for the production and sale of counterfeit drugs and inferior drugs. The draft adheres to the chaos of the code, strengthens the supervision of the whole process, and modifies the outstanding problems exposed by the problem vaccine cases, and responds to social concerns in a timely manner.
 
The draft stipulates that the fine for the production and sale of counterfeit drugs is more than twice or less than the value of the drug, and the fine for serious cases is more than ten times and less than 30 times; the fine for producing and selling inferior drugs is the value of the drug. More than doubled, less than five times, the fine of the serious case is more than five times and less than fifteen times.
 
The draft penalizes those responsible for serious violations. In the case of production or sales of counterfeit and inferior drugs, violation of quality management practices, etc., the legal representative or principal responsible person of the unit, the directly responsible person in charge and other directly responsible personnel shall be punished for confiscation of income, fines, and ten years until the lifetime of the business. .